Stage A & C Sample Data Collection Form



Similar documents
Clinical Study Synopsis

Mellen Center for Multiple Sclerosis

WAKE-Up Pilot Study, Mental Training for patients with relapse-remitting multiple sclerosis and fatigue

DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource

CADC-CAS STUDY GUIDE. Studying for the Exam. Exam Content Outline

Equipment Distribution Program Application 375 Kings Highway North, Cherry Hill, NJ (800) Web:

PACKET OVERVIEW TABLE OF CONTENTS

PCORI Workshop on Treatment for Multiple Sclerosis. Breakout Group Topics and Questions Draft

College Survey for Students with Brain Injury


Multiple Sclerosis: New Perspectives on the Patient Journey

Fatigue in MS: 2005 update B. Colombo University of Milan - HSR

WalkAide. Long term cost effectiveness of FES. J of Rehab Med 2013; 45(2): Humphreys et al

Running Head: INTERNET USE IN A COLLEGE SAMPLE. TITLE: Internet Use and Associated Risks in a College Sample

Version History. Previous Versions. Drugs for MS.Drug facts box fampridine Version 1.0 Author

A blood sample will be collected annually for up to 2 years for JCV antibody testing.

Drugs for MS.Drug fact box cannabis extract (Sativex) Version 1.0 Author

What is Multiple Sclerosis? Gener al information

PHYSICAL CAPACITIES EVALUATION FORM/RESIDUAL FUNCTIONAL CAPACITY ASSESSMENT FORM

Depression: Facility Assessment Checklists

MS an Mental Health. Alison Carolan MS Mental Health Nurse Kings College Hospital. IMPARTS December 2013

Application for MetroAccess Door-to-Door Paratransit Service For People with Disabilities

Austen Riggs Center Patient Demographics

The Relationship Between Anhedonia & Low Mood

MSTAC Initial Application

TECHNICAL/CLINICAL TOOLS BEST PRACTICE 7: Depression Screening and Management

A New MS Consortium for A New MS Clinical Outcome Measure

GLOBAL SURVEY FACT SHEET

Sleep Deprivation and Post-Treatment (CBD)

Multiple Sclerosis Society of Canada. CADA Presentation May 4, 2011

MOLINA HEALTHCARE OF CALIFORNIA

Major Depressive Disorder (MDD) Guideline Diagnostic Nomenclature for Clinical Depressive Conditions

Disease Modifying Therapies (DMTs) in Multiple Sclerosis

Ryokan College Student Profile Program Completion Rates from 1991 to 2011 Program & Graduation Rate Student 85%

Depressive Symptoms Quality Measures Skilled Nursing Facility Setting

Screening Tools and Interventions for Common Behavioral Health Disorders TXPEC

Understanding COPD Questionnaire

PAIN MANAGEMENT. Patient s name: IF YOUR INSURANCE REQUIRES A PRE AUTHORIZATION / REFERRAL FORM, PLEASE OBTAIN PRIOR TO YOUR VISIT.

Prior Authorization, Pharmacy and Health Case Management Information. Prior Authorization. Pharmacy Information. Health Case Management

Rehabilitation and the role of carers

BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC FAX

Total Males Females (0.4) (1.6) Didn't believe entitled or eligible 13.0 (0.3) Did not know how to apply for benefits 3.4 (0.

Lisa R. Fortuna, MD, MPH Michelle V. Porche, Ed. D Sripallavi Morampudi, MBBS Stanley Rosenberg, PhD Douglas Ziedonis, MD, MPH

Relapsing-remitting multiple sclerosis Ambulatory with or without aid

WHODAS 2.0 World Health Organization Disability Assessment Schedule item version, self-administered

Multiple Sclerosis: What You Need To Know. For Professionals

Major Depressive Disorders Questions submitted for consideration by workshop participants

Case: Cerebral Palsy

Worksite Depression Screening and Treatment: An Innovative, Integrated Program

Substance Abuse Services (Outpatient)

BACKGROUND. ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes

Psychological Self Care in Multiple Sclerosis: A Stepped Care Model

Review Date: March Issue Status: Approved Issue No: 2 Issue Date: March 2010

DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE

Dr. Anna M. Acee, EdD, ANP-BC, PMHNP-BC Long Island University, Heilbrunn School of Nursing

Schneps, Leila; Colmez, Coralie. Math on Trial : How Numbers Get Used and Abused in the Courtroom. New York, NY, USA: Basic Books, p i.

CROSSROADS ENROLLMENT APPLICATION (Please carefully read and print all answers. All blank spaces must be filled.)

PSYCHOLOGICAL AND NEUROPSYCHOLOGICAL TESTING

University of Georgia Honors Program

REVISED E-Health Patient Screening Survey


Measurement Tool for Clinical Practice Guideline Implementation: Measures for Depression

SCAT Application. (1) SCAT Eligibility Questionnaire Form and (2) Professional Verification Form

A Quick Guide to Constructing an SPSS Code Book Prepared by Amina Jabbar, Centre for Research on Inner City Health

Staying Mobile & Active Post Stroke. Kevin Lockette PT Ohana Pacific Rehab Services, LLC Honoulu- Kailua

Adult Foster Home Screening and Assessment and General Information

Disclosures. Andrew Moore, LPC has no financial i interests or relationships to disclose. HRSA Education Committee staff have no financial interest

CCC Hooper Detoxification Stabilization Center. Accessing Services

Robot suit HAL. The use of exoskeletons in rehabilitation and as assistive technology to enable equal participation

Application for Transportation Service

Assessment of depression in adults in primary care

Annual Outcome Comparison Report-Source One/Village Jan 1, thru Dec 31, 2013

International Journal of Economics, Commerce and Management United Kingdom Vol. II, Issue 2, 2014

Neurodegenerative diseases Includes multiple sclerosis, Parkinson s disease, postpolio syndrome, rheumatoid arthritis, lupus

Estimated Population Responding on Item 25,196,036 2,288,572 3,030,297 5,415,134 4,945,979 5,256,419 4,116,133 Medicare 39.3 (0.2)

Foot and Ankle Outcomes Questionnaire

Prior Authorization, Pharmacy and Health Case Management Information. Prior Authorization. Pharmacy Information. Health Case Management

Transcription:

Stage A & C Sample Data Collection Form Instructions: Review a minimum of 20 patient charts (or another number determined to be appropriate) from patients most recently admitted, and complete this Data Collection Form, one form per patient chart. This form and the questions included can be customized to meet your needs. The questions relating to specific performance measures are identified (*) other questions are included to provide additional information should you be interested in analyzing it. 1. Patient ID (assign a unique identifier to help you track, should you need to review the patient chart at a later time) 2. Gender Male Female 3. Age Under 20 21-30 31-40 41-50 51-60 61-70 71-80 80+ 4. Ethnicity African American Asian Caucasian Latino/Hispanic Other

5. Date of first visit (mm/yyyy) 6. Date of MS diagnosis (mm/yyyy) * 7. Has the patient been assessed for symptoms of DEPRESSION? 8. Was the patient assessed for depression at first visit? NA (not available) 9. How were the patient s depression symptoms assessed? (check all that apply) Two-question screening test Beck Depression Inventory (BDI) Patient Health Questionnaire (PHQ-9) Other: * 10. Was a diagnosis of depression made? (If you answered for this patient, please skip to question #16) * 11. Is there a documented care plan for managing the patient s depression? 12. If yes, what is included in the care plan? (check all that apply) Psychiatric Referral Pharmacotherapy (single medication) Pharmacotherapy (more than one medication) 13. Is there documented periodic assessment of effectiveness of depression management?

14. Were assessments made at every visit? 15. Was there a change in medication or dose based on the reassessment? * 16. Has the patient been assessed for symptoms of FATIGUE? 17. Was the patient assessed for fatigue at first visit? NA (not available) 18. How were the patient s fatigue symptoms assessed? (check all that apply) Patient detailed history Krupp s Fatigue Severity Scale (FSS) Modified Fatigue Impact Scale (MFIS) Other: * 19. Were fatigue symptoms recorded for this patient? (If you answered for this patient, please skip to question #27) * 20. Is there a documented care plan for managing the patient s fatigue? 21. If yes, what is included in the care plan? (check all that apply) Behavioral Modification (eg, pacing or relaxation) Pharmacotherapy (single medication) Pharmacotherapy (more than one medication) Other

22. Is there documented periodic assessment of effectiveness of fatigue management? 23. Were assessments made at every visit? 24. Has the plan been modified based on reassessment of the patient s fatigue? 25. Was there a change in non-pharmacologic therapy based on the reassessment? 26. Was there a change in medication or dose based on the reassessment? * 27. Has the patient been assessed for MOBILITY IMPAIRMENTS/FALLS? 28. If yes, was the patient s mobility assessed at first visit? NA (not available) 29. How was the patient s mobility assessed? (check all that apply) Neurological Exam Expanded Disability Status Scale (EDSS) 12-item MS walking scale (MSWS-12) Timed 25-foot walk test Other:

30. Which level of ambulation was recorded for the patient? Requires no assistance Requires minimal assistance (eg, handrail) Requires cane or walker Requires wheelchair or scooter ambulation level recorded * 31. Were mobility impairments/falls recorded for this patient? (If you answered for this patient, please skip to question #39) * 32. Is there a documented care plan for managing the patient s mobility impairments? 33. If yes, what is included in the care plan? (check all that apply) Physical therapy/rehabilitation Pharmacotherapy (single medication) Pharmacotherapy (more than one medication) 34. Is there documented periodic assessment of effectiveness of mobility management? 35. Were assessments made at every visit? 36. Has the plan been modified based on reassessment of the patient s mobility? 37. Was there a change in non-pharmacologic therapy based on the reassessment?

38. Was there a change in medication or dose based on the reassessment? * 39. Has the patient been assessed for symptoms of SPASTICITY? 40. If yes, was the patient assessed for spasticity at first visit? NA (not available) 41. How were the patient s spasticity symptoms assessed? (check all that apply) Ashworth or Modified Ashworth score Neurological Exam Other: * 42. Were spasticit y symptoms recorded for this patient? (If you answered for this patient, stop here) * 43. Is there a documented care plan for managing the patient s spasticity symptoms? 44. If yes, what is included in the care plan? (check all that apply) Physical therapy/rehabilitation Pharmacotherapy (single medication) Pharmacotherapy (more than one medication) 45. Is there documented periodic assessment of effectiveness of spasticity management? 46. Were assessments made at every visit?

47. Has the plan been modified based on reassessment of the patient s spasticity? 48. Was there a change in non-pharmacologic therapy based on the reassessment? 49. Was there a change in medication or dose based on the reassessment?

Measure # I II Constructing an Adaptive Care Model for the Management of Disease Related Symptoms Throughout the Course of Multiple Sclerosis Performance Measures and Calculation Instructions Symptom Performance Measure Numerator Numerator Calculation Depression documented assessment documented care plan assessment for depression care plan for managing depression of "" responses to Question 7 of "" responses to Question 11 Denominator All residents All residents with documented diagnosis of depression Denominator Calculation number of patient charts reviewed number of "" responses to Question 10 III IV V VI Fatigue Mobility Impairment/ Falls documented assessment documented care plan documented assessment documented care plan assessment for fatigue care plan for managing fatigue assessment for mobility impairments/falls care plan for managing mobility impairments of "" responses to Question 16 of "" responses to Question 20 of "" responses to Question 27 of "" responses to Question 32 All residents All residents with documented fatigue symptoms All residents All residents with documented mobility impairment/falls number of patient charts reviewed number of "" responses to Question 19 number of patient charts reviewed number of "" responses to Question 31 VII VIII Spasticity documented assessment documented care plan assessment for symptoms of spasticity care plan for managing spasticity of "" responses to Question 39 of "" responses to Question 43 All residents All residents with documented spasticity symptoms number of patient charts reviewed number of "" responses to Question 42 Source: Cheng et al. Quality indicators for MS. Multiple Sclerosis. 2010;16(8):970 980. The Academy for Continued Healthcare Learning.